Oncology Drug Prices In US, Europe Misaligned With Clinical Value Assessments
Executive Summary
Study's finding is somewhat surprising for Europe, given the greater national involvement in drug prices in the region; ASCO and ESMO value frameworks don't appear to drive oncology pricing decisions regardless of the reimbursement system.